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Objective: To evaluate the safety proﬁle and antioxidant activity of fatty hydroxamic
acid (FHA) from the seed oil of Cyperus esculentus (C. esculentus).
Methods: FHA was synthesized from the seed oil of C. esculentus via a two-step re-
action system. The FHA was later subjected to antioxidant activity test using 2, 2-
diphenyl-1-picyrl hydrazyl assay. Additionally, adult male Wistar rats were randomly
assigned to four groups of ﬁve rats each and were orally administered with FHA at 0, 5,
15 and 50 mg/kg for seven days. Clinical observations and serum biochemical parameters
were assessed to monitor treatment–related adverse effects in the rats.
Results: Fourier transform infrared spectra showed that FHA was synthesised from the
seed oil of C. esculentus. The antioxidant property of FHA increased as the concentration
reduced below 0.05 mg/mL. Result of oral administration of FHA revealed no adverse
effect levels at the dose of 5 mg/kg/day. However, the adverse effects seen in rats
receiving 15 mg/kg/day (the least observed adverse effect level) were signiﬁcant increase
in alkaline phosphatase activity, triglycerides, and creatinine levels. Moderate hyper-
albuminemia and hypoalbuminemia resulted in an increased albumin/globulin ratio.
These effects might be the result of a physiological response to exposure to a very high
level of FHA which is not part of the normal diet, and are most likely not toxicologically
relevant.
Conclusions: C. esculentus has been presented as a potential source of feed stock for the
synthesis of a relatively cheap and non toxic FHA which has antioxidant and free-radical
scavenging activity.1. Introduction
Hydroxamic acid is known as an important family of organic
bioligands which is considered to be derivatives of hydroxyl-
amine and carboxylic acids as seen in Figure 1; one of its earlier
physiological importances being associated with its use as
siderophores[1]. Over the years, there has been increasing interest
in its roles as potent and selective inhibitors of a range of
enzymes[2–4]. It has also been reported as chemotherapeutic
agents[5,6] while a number of its derivatives have been reported
as pharmaceutics in treating cancer, cardiovascular diseases,
hypertension, tuberculosis and fungal infections[7]. Speciﬁc
derivatives of hydroxamic acid such as suberoylanilidehydroxamic acid has been reported to be a potent inhibitor of
histone deacetylases, and possesses anticancer and apoptosis
effect against several tumour types[8,9].
Chemically, hydroxamic acid and its derivatives have been
shown to be nitric oxide donors by way of their chemical
reactivity. Their biological activity has also been attributed to the
strong metal ion chelating ability and the nitric oxide releasing
properties[10]. Its ability to delay the oxidation of other molecules
by inhibiting the initiation or propagation of oxidizing chain
reactions suggests them as potential antioxidants[11]. It has the
ability of reacting with single free radicals to form neutral
molecules due to its ability to donate electrons and as
potential antioxidants; they may be able to prevent cell and
tissue damage as they act as scavenger[12].
Although hydroxamic acid and a number of its derivatives
have been synthesised from simple ﬁne chemicals, they have
been shown to be expensive and may have environmental con-
cerns[13–15]. There have been little reports on the use of biomassserved.
Figure 1. The general structure of hydroxamic acid.
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biomass such as seed oils as feed stock in oleochemicals is
important in replacing petrochemicals; such biomass will lead
to a product which is cost effective, biodegradable and
environmentally friendly. Underutilized seed oil such as tiger
nut [Cyperus esculentus (C. esculentus)] oil is an example of
biomass feed stock which can be used to achieve this purpose.
C. esculentus commonly called tiger nut belongs to the
Cyperaceae family of plant species. The tubers are about the size
of peanuts and are commonly found in Nigeria[16]. Research
studies have shown that 100 g tiger nuts contain 386 kcal
(1635 kj) as 7% proteins, 36% fats (oils), 31% starch, 21%
glucose, 26% ﬁber of which 14% is non-soluble and 12% sol-
uble, mineral and vitamin E and C indicating the possibility of
C. esculentus tuber being exploited[17,18]. The nut was found to be
rich in myristic acid, oleic acid and linoleic acid[19]. It has been
reported to reduce the risk of colon cancer with positive effect on
cholesterol level due to high content of vitamin E[20]. Since the
seed contains about 36% oil, it is considered as a good source
of seed oil. The fatty acid composition of the oil has been
reported to be mainly oleic, linoleic and palmitic acids[21–23].
Aside the synthesis from biomass, the establishment of the
toxicity level of such bio-based hydroxamic acid is crucial. In
response to this, the present work has evaluated the synthesis of
fatty hydroxamic acid (FHA) from underutilized seed oil of
C. esculentus. The antioxidant properties of the FHA and its
toxicity proﬁle in blood clinical parameters were also examined.
2. Materials and methods
2.1. Materials
The seeds of C. esculentus were purchased from Festac Town
market in Lagos State, Nigeria and identiﬁed at the Herbarium
Unit, Botany Department University of Ibadan. They were air
dried and subsequently ground in a laboratory mill. The ground
seeds of C. esculentus were later extracted with n-hexane for
10 h using a soxhlet extractor[23].
2.2. Methyl esters from the seed oil of C. esculentus
Oil of C. esculentus was converted to methyl esters as pre-
viously described by Adewuyi et al[24]. Brieﬂy, the oil was ﬁrstly
pre-treated using 2% sulphuric acid in methanol at 70 C for 2 h
to convert the free fatty acid content of the oil to methyl esters.
The resultant product was extracted with ethyl acetate, washed
with water until free of acid, passed over sodium sulphate and
concentrated using a rotary evaporator. The pre-treated oil was
ﬁnally transesteriﬁed using 1% KOH in methanol at 70 C. Themethyl esters formed were extracted with ethyl acetate, washed
with water until free of KOH and dried over sodium sulphate
while ethyl acetate was removed using a rotary evaporator.
2.3. Synthesis of hydroxamic acid
Hydroxamic acid was synthesised by adding 2.75 g
(0.04 moL) sample of hydroxylamine hydrochloride to
16.50 mL of water in a 250 mL Erlenmeyer ﬂask. This was
gently warmed after which 11 mL of potassium hydroxide
(0.05 moL) and 1.1 g of fatty methyl esters of C. esculentus oil
were added followed by ethanol (15 mL) to give a clear solution.
The mixture was warmed in a water bath for 15 min after which
it was cooled in an ice bath. The resulting solid was ﬁltered and
dried to give hydroxamic acid. The progress of the reaction was
monitored using Fourier transform infrared spectroscopy (FTIR)
spectrophotometer (Schimadzu, 8400 s).
2.4. In vitro anti-oxidant assay
The antioxidant activity of the C. esculentus FHA was
measured using 2,2-diphenyl-1-picyrl hydrazyl (DPPH) assay as
described in our previous study[25]. This spectrophotometric
assay uses the stable radical DPPH as a reagent. The DPPH
free radical was prepared at a 0.1 mmol/L concentration
(2.5 mg/L) in methanol while radical was prepared, protected
from light and refrigerated[26]. The sample stock solution
(10 mg/mL) was diluted to ﬁnal concentrations of 0.1–
0.05 mg/mL. The dilutions were prepared in triplicate and
1 mL of DPPH was added to each concentration of triplicate
which was incubated in the dark for 30 min while absorbance
was taken at 518 nm. Control experiment was carried out to
determine the absorbance of DPPH before interacting with the
hydroxamic acid. Blank experiment was also carried out to
determine the absorbance of the sample without DPPH.
Absorbance was recorded to check the stability of the radical
throughout the time of analysis. The total antioxidant activity
was calculated using the following equation[27]:
Total antioxidant activity = 100 ×
Abscontrol −Abssample
Abscontrol
2.5. Animals and treatment
Twenty male adult albino rats of the Wistar strain, weighing
between 270 and 300 g were used in this study. Animals were
obtained from the primate colony of the Department of Veteri-
nary Anatomy, University of Ibadan. Rats were fed on com-
mercial pelleted diet (Ladokun Feeds Ibadan, Nigeria) and
drinking water ad libitum, maintained under standard laboratory
conditions and subjected to natural photoperiod of 12 h light/
12 h dark cycle. Rats were randomly assigned into four groups
of ﬁve rats each. Rats in Group A served as controls and
received distilled water. Group B rats were treated with FHA at
the dose of 5 mg/kg body weight/day and Rats in Groups C and
D were treated with FHA at a dose of 15 mg/kg and 50 mg/kg
body weight/day, respectively. These doses represent low, me-
dium and high doses. All treatments were given, orally, once
daily for seven days. During the experimental period, all animals
were observed daily for clinical signs and symptoms of toxicity.
The animals were sacriﬁced 24 h after the last treatment. All
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laboratory animals as outlined by the Redeemer's University
Committee on Ethics for Scientiﬁc Research.
2.5.1. Preparation of samples
Rats were sacriﬁced by cervical dislocation and blood sam-
ples were collected by cardiac puncture into clean plain bottles
and centrifuged at 4000 g for 10 min (Heraeus Labofuge 300,
Thermo Scientiﬁc, Hampshire UK). Serum was carefully sepa-
rated out and stored frozen until required for analysis.
2.5.2. Serum biochemical analyses
Biochemical analyses were carried out to determine the
serum concentrations of alanine and aspartate aminotransferases,
alkaline phosphatase, lactate dehydrogenase, gamma glutamate
transferase, bilirubin, albumin, total cholesterol, triglyceride and
creatinine using diagnostic kits (Randox Laboratories Limited,
Crumlin, United Kingdom) as reported in our previous
studies[28].
2.6. Data analysis
All data were expressed as mean ± SEM. Differences be-
tween the groups were determined by One-way ANOVA and
post hoc testing was performed using Dunnett's test (Graph Pad
Prism 3 software). Values were regarded as signiﬁcantly
different at P < 0.05.
3. Results
3.1. Synthesis
Light golden coloured oil was obtained from the seed of
C. esculentus which was ﬁrst converted to methyl esters and
ﬁnally FHA via simple reaction steps. The FTIR results provided
clear and convincing evidence regarding the chemical structure,Figure 2. Anti-oxidant capacity of FHA from C. esculentus.
Table 1
Effect of FHA on body weight, liver and kidney weights of rats.
Variables Control 5 m
Final body weight (g) 302.50 ± 8.50 302.5
Liver weight (g) 7.90 ± 0.22 7.1
L/B (%) 2.61
Kidney weight (g) 1.40 ± 0.06 1.4
K/B (%) 0.47
Values are expressed as mean ± SEM. B: Final body weight; L: Liver weigmainly from amide-type carbonyl, NH bending, and OH/NH
stretching bands. Certain peaks found in the spectrum of the oil
before the reactions were not seen in that of FHA establishing
that chemical reaction has taken place.
3.2. In vitro anti-oxidant assay
As presented in Figure 2, the antioxidant property of the
synthesized FHA increased as the concentration reduced. On the
other hand, on increasing the concentration of the FHA above
0.05 mg/mL, the anti-oxidant capacity FHA reduces and tends
toward being a pro-oxidant. The half maximal IC50 was found to
be 185.10 ± 0.04 mg/mL. This measures the effectiveness of
FHA in scavenging for free radicals.
3.3. Clinical chemistry studies
3.3.1. Effect of FHA on body weight, liver and kidney
weights of rats
Table 1 showed the effect of FHA on body and organ weight.
FHA administered to rats at the doses of 5, 15 and 50 mg/kg did
not alter body, absolute/relative liver and kidney weights in
these animals when compared with control.
The results of the total cholesterol and triglycerides levels are
also presented in Table 2. Administration of FHA at all treat-
ment doses did not signiﬁcantly affect the total cholesterol levels
when compared with the control, however, the triglyceride levels
were signiﬁcantly elevated upon treatment at 15 and 50 mg/kg.
This contradicted an earlier study by Izydore et al. which re-
ported the hypolipidemic activities of benzohydroxamic acid
and dibenzohydroxamic acids in mice and rats at a dose of
20 mg/kg/day[29]. Increase in serum triglyceride level, as
observed in this present study, may indicate impairment of
lipid metabolism in the animals. Serum level of creatinine is
an indicator of renal function. The result of this study showed
that per os administration of FHA increased the level of serum
creatinine at all treatment doses. This is an indication that
FHA may adversely impair the glomerular ﬁltration function
of the kidney. This may also be possibly due to increased
catabolic state in the rats from prolonged appetite[30].
3.3.2. Effect of FHA on some blood clinical chemistry
indices
Animals treated with FHA at a dose of 15 mg/kg showed a
statistically signiﬁcant decrease (P < 0.05) in mean total protein
level when compared with control. This may be due to decrease
in the constitutive globulin fraction. Also, a non-signiﬁcant in-
crease in albumin level was also observed in all treatment groups
in comparison with controls indicating that the synthesis of the
protein by the liver was not adversely affected by the ingestion
of FHA.g/kg 15 mg/kg 50 mg/kg
0 ± 6.30 315.00 ± 6.50 310.00 ± 5.80
0 ± 0.41 8.10 ± 0.57 6.70 ± 0.41
2.35 2.58 2.16
0 ± 0.04 1.40 ± 0.06 1.30 ± 0.13
0.46 0.46 0.42
ht; K: Kidney weight.
Table 2
Effect of FHA on some serum constituents in rats.
Variables Control 5 mg/kg 15 mg/kg 50 mg/kg
Total protein (g/dL) 20.40 ± 0.58 18.60 ± 1.37 16.30 ± 0.28a 16.60 ± 0.88
Albumin (g/dL) 10.70 ± 1.25 11.80 ± 2.00 12.40 ± 1.27 12.4 ± 2.0
Globulin (g/dL) 9.70 ± 0.71 6.80 ± 0.31 3.90 ± 0.28 4.20 ± 0.92
A/G ratio 1.10 ± 0.08 1.80 ± 0.50 3.30 ± 0.26b 2.60 ± 0.42a
Bilirubin (mg/dL) 0.19 ± 0.01 0.17 ± 0.01 0.14 ± 0.02 0.25 ± 0.01a
Cholesterol (mg/dL) 284.90 ± 7.38 253.70 ± 11.19 256.20 ± 14.21 276.40 ± 6.64
Triglyceride (mg/dL) 385.60 ± 8.57 383.20 ± 8.20 338.40 ± 11.01a 334.80 ± 11.26b
Creatinine (mg/dL) 36.90 ± 9.52 82.00 ± 10.26a 112.80 ± 5.91b 102.60 ± 10.34b
Values are expressed as mean ± SEM of ﬁve animals per group. a: Signiﬁcantly different from control (P < 0.05); b: Signiﬁcantly different from control
(P < 0.01); A: Albumin; G: Globulin.
Figure 3. Effect of FHA from C. esculentus on activities of serum enzyme markers, AST, ALT, ALP, g-GT and LDH in rats (mg/kg).
a: Signiﬁcantly different from control (P < 0.05); Enzyme activity is quantiﬁed as IU/L.
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In our study (Figure 3), FHA administered at the different
doses did not cause any signiﬁcant change in alanine amino-
transferase (ALT), lactate dehydrogenase (LDH) and g-glutamyl
transferase (g-GT) activities, whereas aspartate aminotransferase
(AST) and alkaline phosphatase (ALP) activities were signiﬁ-
cantly elevated (P < 0.05) when compared with control at a
50 mg/kg dose of FHA. g-GT activity was not adversely
affected just as there was no disproportionate elevation of LDH.
4. Discussion
Both spectral of oil and FHA have peaks at 3007 cm−1,
2922 cm−1 and 2852 cm−1 corresponding to the vibrational
frequencies of unsaturated carbon bonds (CH]CH), methyl
alkane (CH3) and the methylene groups (CH2). The absorption
band for the ester functional group was found at 1745 cm−1 in
the oil which disappeared after the reaction with the appearance
of characteristic bands at 1560 cm−1(C–N–C) and 1653 cm−1
(C]O). A peak was also found at 3387 cm−1 which can be
attributed to the OH functional group in FHA; these peaks
suggest the formation of FHA[31,32]. Peaks found at 1425 and
1464 cm−1 in FHA were also accounted for as being the C–N
absorption bands while the N–O vibrational frequency
appeared at 923 cm−1. The design and synthesis of
oleochemicals from biomass for industrial applications in
ﬁelds such as Biomedical Sciences has been of great
importance[33]. FHA falls into this group of oleochemicals with
tremendous industrial applications which may be attributed to
its expected reactivity, low toxicity and wide spectrum ofactivities in biological systems[34,35]. From the present study,
FHA was synthesized from C. esculentus seed oil with the
yield of FHA being 94%. This high yield of 94% suggests
C. esculentus seed oil as a good source of FHA.
Molecular oxygen and its reaction products such as super-
oxide radical and hydrogen peroxide generate free radicals that
can cause injury to biological organisms; such damage may
result in protooncogene activation and/or suppressor gene
inactivation[36]. Antioxidants are required to scavenge these free
radicals from biological systems in order to avert or cancel out
the cell-damaging effects of free radicals. This present study
has used DPPH as a stable free radical that can easily accept an
electron or hydrogen radical to become a stable diamagnetic
molecule; which is a typical means of evaluating the antioxidant
potential of substances[36,37]. From the results obtained,
antioxidant property of the synthesized FHA increased with a
reduction in its concentration while on increasing its
concentration above 0.05 mg/mL, the antioxidant capacity
reduces and tends toward being a pro-oxidant. This observa-
tion had also been previously reported that aside from antioxi-
dants being reducing agents they can also act as pro-oxidants[37–
41].
Analysis of organ weight in toxicology studies is an impor-
tant endpoint for identiﬁcation of potentially harmful effects of
chemicals. The measured body weight and organs did not
change when compared with control. This observation correlated
with another study reported that administration of sub-
eroylanilide hydroxamic acid to rats at doses of 15 and 50 mg/
kg/day for 14 days did not elicit any treatment-related decreases
in body weight[42].
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the doses of 15 and 50 mg/kg, but these increments were not
dose dependent. Based on clinical interpretations, the phenom-
enon of increased A/G ratio is not clinically signiﬁcant. Bilirubin
is a yellow pigment produced when heme is catabolized. In this
study, we observed a one fold increase in serum total bilirubin
levels in the FHA-treated (50 mg/kg) rats compared with the
control rats. This consequent hyperbilirubinemia may result
from ineffective erythropoiesis or an impaired ability of the liver
to excrete normal amounts of bilirubin[43].
Liver function tests are commonly used in clinical practice to
screen for liver disease, monitor the progression of known dis-
ease, and monitor the effects of potentially hepatotoxic drugs.
The most common liver function tests include the serum ami-
notransferases, alkaline phosphatase, bilirubin, albumin, and
prothrombin time. Aminotransferases, such as ALT and AST,
measure the concentration of intracellular hepatic enzymes that
have leaked into the circulation and serve as a marker of he-
patocyte injury. Alkaline phosphatase, g-GT and bilirubin act as
markers of biliary function and cholestasis. Albumin and pro-
thrombin reﬂect liver synthetic function[44]. There was no
signiﬁcant change in ALT, LDH, and g-GT activities. Yeboah
and others have studied the phytosterols and the vitamin E
content of C. esculentus[45]. They reported the presence of total
vitamin E content (120.1 mg/g of oil) and high amounts of
phytosterol such as b-sitosterol, stigmasterol and campesterol.
This moderately high content of phytosterols and Vitamin E
could protect the liver from oxidative damage by preventing
free radical formation or scavenging already-formed free radi-
cals. The ability of FHA to scavenge the DPPH radical also
corroborates this protective mechanism. On the contrary, AST
and ALP activities were signiﬁcantly elevated (P < 0.05) rela-
tive to control following administration of FHA at a dose of
50 mg/kg. But because of the cellular distribution of ALP,
increased serum activity may be caused by a wide variety of
disorders. Consequently, ALP values are interpreted in tandem
with other clinical indices. In our study, there was no dispro-
portionate elevation of LDH which suggested the absence of
multi-organ system disease. Likewise g-GT activity was not
adversely affected in all treatment groups, so this precluded the
hepatobiliary system as the source of the elevated ALP. This
observed increase in ALP and AST could be more of physio-
logical than pathological as a result of the high fatty acid content
of the FHA[46].
FTIR spectroscopy showed that FHA based on C. esculentus
seed oil was successfully prepared. Advantages of this synthesis
from the seed oil include ease of preparation from the seed oil of
C. esculentus which is a cheap source and moderate reaction
conditions consistent with green chemistry principles. Also in
this paper we showed that FHA has antioxidant and free-radical
scavenging activity. It was also observed that FHA was not
overly toxic to the liver, although care must be exercised during
formulation to avoid target organ toxicity.
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